Sedana Medical AB (publ), Year-end report, 2019
Another strong quarter with increased sales growthFinancial Summary October-December · Net sales during the fourth quarter amounted to 20 056 (15 242) KSEK corresponding to an increase of 32% compared with the same period in 2018. · Earnings before interest, taxes, depreciation and amortisation (EBITDA) amounted to -3 979 (-1 474) KSEK. This corresponds to an EBITDA margin of -20% (-10%). · Earnings before interest and taxes (EBIT) amounted to -5 038 (-2 450) KSEK which corresponds to an EBIT margin of -25% (-16%). · Cash flow from operations before changes in working capital